These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 32094324)
1. Discovery of suppressors of CRMP2 phosphorylation reveals compounds that mimic the behavioral effects of lithium on amphetamine-induced hyperlocomotion. Zhao WN; Tobe BTD; Udeshi ND; Xuan LL; Pernia CD; Zolg DP; Roberts AJ; Mani D; Blumenthal SR; Kurtser I; Patnaik D; Gaisina I; Bishop J; Sheridan SD; Lalonde J; Carr SA; Snyder EY; Haggarty SJ Transl Psychiatry; 2020 Feb; 10(1):76. PubMed ID: 32094324 [TBL] [Abstract][Full Text] [Related]
2. CRMP2 mediates GSK3β actions in the striatum on regulating neuronal structure and mania-like behavior. Kim W; Won SY; Yoon BJ J Affect Disord; 2019 Feb; 245():1079-1088. PubMed ID: 30699850 [TBL] [Abstract][Full Text] [Related]
3. Probing the lithium-response pathway in hiPSCs implicates the phosphoregulatory set-point for a cytoskeletal modulator in bipolar pathogenesis. Tobe BTD; Crain AM; Winquist AM; Calabrese B; Makihara H; Zhao WN; Lalonde J; Nakamura H; Konopaske G; Sidor M; Pernia CD; Yamashita N; Wada M; Inoue Y; Nakamura F; Sheridan SD; Logan RW; Brandel M; Wu D; Hunsberger J; Dorsett L; Duerr C; Basa RCB; McCarthy MJ; Udeshi ND; Mertins P; Carr SA; Rouleau GA; Mastrangelo L; Li J; Gutierrez GJ; Brill LM; Venizelos N; Chen G; Nye JS; Manji H; Price JH; McClung CA; Akiskal HS; Alda M; Chuang DM; Coyle JT; Liu Y; Teng YD; Ohshima T; Mikoshiba K; Sidman RL; Halpain S; Haggarty SJ; Goshima Y; Snyder EY Proc Natl Acad Sci U S A; 2017 May; 114(22):E4462-E4471. PubMed ID: 28500272 [TBL] [Abstract][Full Text] [Related]
4. Modeling Complex Neurological Diseases with Stem Cells: A Study of Bipolar Disorder. Pernia CD; Nathan NH; Tobe BTD; Winquist AM; Sidman RL; Goshima Y; Snyder EY Results Probl Cell Differ; 2018; 66():265-282. PubMed ID: 30209664 [TBL] [Abstract][Full Text] [Related]
5. The role of lithium in the treatment of bipolar disorder: convergent evidence for neurotrophic effects as a unifying hypothesis. Machado-Vieira R; Manji HK; Zarate CA Bipolar Disord; 2009 Jun; 11 Suppl 2(Suppl 2):92-109. PubMed ID: 19538689 [TBL] [Abstract][Full Text] [Related]
6. The mood stabilizing properties of AF3581, a novel potent GSK-3β inhibitor. Capurro V; Lanfranco M; Summa M; Porceddu PF; Ciampoli M; Margaroli N; Durando L; Garrone B; Ombrato R; Tongiani S; Reggiani A Biomed Pharmacother; 2020 Aug; 128():110249. PubMed ID: 32470749 [TBL] [Abstract][Full Text] [Related]